Extracellular Vesicles and Circulating Nucleic Acids (EVCNA) is an international, peer-reviewed, open access journal.
Extracellular Vesicles and Circulating Nucleic Acids provides an online platform for the sharing of research data, new methodology, reviews and commentaries in the areas of extracellular vesicles and circulating nucleic acids including DNA, RNA, and miRNA and their therapeutic use. The journal is committed to the rapid publication of original findings that increase our understanding of the molecular and cell biology, biogenesis, and origin of extracellular vesicles and circulating nucleic acids; and their use as biomarkers for the diagnosis, prognostication and surveillance of disease states, and in therapeutics. Manuscripts with clinical relevance are especially encouraged to promote the translation from basic science to clinical applications. The criteria for acceptance are scientific excellence and originality. All works involving the use of animals and human subjects must have been approved by institutional review committees and adhere to accepted international ethical standards.
All articles published by EVCNA are made freely and permanently accessible online immediately from the date of publication. For further information, please refer to Open Access. Articles are published under a Creative Commons Attribution 4.0 International License (CC BY). The CC BY allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license users are free to share (copy, distribute and transmit) and remix (adapt) the contribution for any purposes, even commercially, provided that the users appropriately acknowledge the original authors and the source.
Authors retain the copyright of their works as well as the rights to make certain uses of the works.
For more information about the editorial team, please refer to Editorial Board.
All manuscripts submitted to EVCNA should adhere to EVCNA's Editorial Policies.
All articles in this journal have undergone editorial screening and a single-blind peer review by at least two reviewers. For more details, please refer to Editorial Process and Peer Review Guidelines.
Please visit the Contact Us for details about different queries.